266 related articles for article (PubMed ID: 1419801)
1. Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.
Terpstra WE; Lokhorst HM; Blomjous F; Meuwissen OJ; Dekker AW
Br J Haematol; 1992 Sep; 82(1):46-9. PubMed ID: 1419801
[TBL] [Abstract][Full Text] [Related]
2. Histomorphology of multiple myeloma on bone marrow biopsy.
Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
[TBL] [Abstract][Full Text] [Related]
3. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
[TBL] [Abstract][Full Text] [Related]
4. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bone marrow histology in multiple myeloma.
Subramanian R; Basu D; Dutta TK
Indian J Cancer; 2009; 46(1):40-5. PubMed ID: 19282565
[TBL] [Abstract][Full Text] [Related]
6. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
[TBL] [Abstract][Full Text] [Related]
7. Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma.
Marmont F; Pich A; Chiusa L; Locatelli F; Falda M; Boccadoro M; Resegotti L
Eur J Haematol; 1996; 56(1-2):39-44. PubMed ID: 8599992
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.
Bartl R; Frisch B; Diem H; Mündel M; Fateh-Moghadam A
Eur J Haematol Suppl; 1989; 51():88-98. PubMed ID: 2697597
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.
Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E
J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532
[TBL] [Abstract][Full Text] [Related]
11. [Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications].
de la Rosa Alcaide MA; Hernández Nieto L; Hernández García MT; Brito Barroso ML
Sangre (Barc); 1989 Aug; 34(4):313-4. PubMed ID: 2772787
[No Abstract] [Full Text] [Related]
12. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
[TBL] [Abstract][Full Text] [Related]
13. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
Charles KS; Winfield DA; Angel C; Goepel J
Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma.
Cavo M; Baccarani M; Gobbi M; Lipizer A; Tura S
Br J Haematol; 1983 Dec; 55(4):683-90. PubMed ID: 6671088
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma].
Su JY; Tao Y; Liu YZ; Zhou LY; Yang LP; Liu H; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1389-91. PubMed ID: 23257439
[TBL] [Abstract][Full Text] [Related]
17. [Optimizing plasma cell content in bone marrow aspirates].
Hoffmann T; Favre G; Gratwohl A; Passweg J; Mathys S; Borel J; Speck B; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1611-3. PubMed ID: 9824893
[TBL] [Abstract][Full Text] [Related]
18. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.
Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK
Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]